Regulus Therapeutics Inc.

RGLSDelisted Jun 25, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001505512

SEC filings (opens in a new tab)

Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Regulus Therapeutics Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of RGLS: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	27	26	−1
Shares	8.05M	10.2M	+2.13M (+26.5%)
Value	$6.82M	$15.0M	+$8.14M (+119.4%)

New holders (1)

Institutions that held Regulus Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to RGLS in Q2 2023
Institution	Shares	Value	% of portfolio
Prelude Capital Management, LLC	40,660	$59.8K	0.00%

Sold out (2)

Institutions that held Regulus Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of RGLS in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Jane Street Group, LLC	18,189	$15.4K
Group One Trading, L.P.	492	$417